Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-02-27
2007-02-27
Siew, Jeffrey (Department: 1642)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S325000, C435S320100, C530S350000
Reexamination Certificate
active
10244586
ABSTRACT:
A novel isolated and purified human protein inhibitor of apoptosis, termed livin, is described. A cDNA sequence which encodes the native inhibitor of apoptosis (livin) is disclosed as well as the structural coding region and the amino acid residue sequence. Molecular sequences are provided for the design and synthesis of entities that modulate biological and/or pharmacological activity of the native biomolecule. Methods are provided which employ the sequences to identify compounds that modulate biological and/or pharmacological activity of the native biomolecule. Biologically-effective antisense molecules as well as dominant negative mutant versions of the livin protein which are suitable for therapeutic are also provided. The invention is also drawn toward the study, prevention, diagnosis, and treatment of pathophysiological disorders related to apoptosis.
REFERENCES:
patent: 4861710 (1989-08-01), Sobel et al.
patent: 6020143 (2000-02-01), St. George-Hyslop et al.
patent: 6284487 (2001-09-01), Stahl et al.
patent: WO 96/35703 (1996-11-01), None
patent: WO 97/06182 (1997-02-01), None
patent: WO 97/17937 (1997-05-01), None
patent: WO 98/22131 (1998-05-01), None
patent: WO 00/08144 (2000-02-01), None
patent: WO 00/23589 (2000-04-01), None
Bowie et al, Science, 1990, 247:1306-1310.
Boehringer Mannheim Biochemicals Catalog, 1994, p. 93, cat #1034 731.
Orkin et al, Report and Recommendations of the Panel to Assess the NIH investment in Research on Gene Therapy, 1995, p. 1-39.
Marshall Science, 1995, 269:1050-1055.
Culver et al, TIG, 1994, 10:174-178.
Liston et al., “Genomic Characterization of the Mouse Inhibitor of Apoptosis Protein 1 and 2 Genes”, Genomics, Dec. 15, 1997, pp. 495-503.
Rajcan-Separovic et al., “Assignment of Human Inhibitor of Apoptosis Protein (IAP) Genesxiap, hiap-1, andhiap-2to Chromosomes Xq25 and 11q22-q23 by Fluorescencein SituHybridization”, Genomics, 1996, vol. 37, No. 3, pp. 404-406.
Young et al., “Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2”, Mammalian Genome, Jan. 1999, vol. 10, No. 1, pp. 44-48.
Ambrosini et al., “A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma”, Nat. Med., Aug. 1997, pp. 917-921.
Duckett et al., “A conserved family of cellular genes related to the baculovirusiapgene and encoding apoptosis inhibitors”; EMBO Journal, 1996, pp. 2685-2689.
Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related of IAP genes”, Nature, Jan. 1996, pp. 349-353.
Rothe et al., “The TNFR2-TRAF Signaling Complex Contains Two Novel Proteins Related to Baculoviral Inhibitor of Apoptosis Proteins”, Cell, Dec. 1995, pp. 1243-1252.
Burgess et al., “Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heparin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue”, Journal of Cell Biology, 1990, vol. 111, pp. 2129-2138.
Lazar et al., “Transforming Growth Factor α: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities”, Molecular and Cellular Biology, 1988, vol. 8, pp. 1247-1252.
Stehlik et al., “Cytokine Induced Expression of Porcine Inhibitor of Apoptosis Protein (iap) Family Member is Regulated by NF-κB”, Biochem Biophys Res Commun, 1998, vol. 243, pp. 827-832 (abstract).
Accession No. U79142.
Accession No. L49432.
Uren et al., “Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors”, PNAS, 1996, vol. 93, pp. 4974-4978.
Accession No. U37546.
Accession No. AAT61591.
Brinbaum et al., “An Apoptosis-Inhibiting Gene from a Nuclear Polyhedrosis Virus Encoding a Polypeptide with Cys/His Sequence Motifs”, Journal of Virology, 1994, vol. 68, pp. 2521-2528 (abstract).
Accession No. L22564.
Accession No. Y17793.
Accession No. AAT14884.
Accession No. AAT65102.
Accession Umber AF007769.
Gomes Bruce C
Kasof Garrett M
Prosser Judith C
Fish & Neave IP Group Ropes & Gray LLP
Goddard Laura
Siew Jeffrey
LandOfFree
Linvin, a novel inhibitor of apoptosis protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Linvin, a novel inhibitor of apoptosis protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Linvin, a novel inhibitor of apoptosis protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3853714